Application 205386

Type
ANDA
Sponsor
MAYNE PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MORPHINE SULFATEMORPHINE SULFATETABLET, EXTENDED RELEASE;ORAL15MGNoNo
002MORPHINE SULFATEMORPHINE SULFATETABLET, EXTENDED RELEASE;ORAL30MGNoNo
003MORPHINE SULFATEMORPHINE SULFATETABLET, EXTENDED RELEASE;ORAL60MGNoNo
004MORPHINE SULFATEMORPHINE SULFATETABLET, EXTENDED RELEASE;ORAL100MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51862-185Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-185Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-185Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-186Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-186Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-186Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-187Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-187Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-187Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-188Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-188Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent
51862-188Morphine SulfateMorphine SulfateMayne Pharma Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
46808ORIG2017-01-13